JPH0158165B2 - - Google Patents

Info

Publication number
JPH0158165B2
JPH0158165B2 JP2044982A JP2044982A JPH0158165B2 JP H0158165 B2 JPH0158165 B2 JP H0158165B2 JP 2044982 A JP2044982 A JP 2044982A JP 2044982 A JP2044982 A JP 2044982A JP H0158165 B2 JPH0158165 B2 JP H0158165B2
Authority
JP
Japan
Prior art keywords
allantoin
water
external preparation
added
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP2044982A
Other languages
Japanese (ja)
Other versions
JPS58140013A (en
Inventor
Minoru Kuroda
Tomoko Kawada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP2044982A priority Critical patent/JPS58140013A/en
Publication of JPS58140013A publication Critical patent/JPS58140013A/en
Publication of JPH0158165B2 publication Critical patent/JPH0158165B2/ja
Granted legal-status Critical Current

Links

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は、アラントインを主成分とする外用剤
に関するものである。ここで外用剤とは顔や手足
などのヒフを保護し健康な状態に保つために外用
する医療用および化粧用の製剤を意味する。 アラントインは化粧品原料基準に収載されてお
り、創傷、潰瘍、火傷等の手当や湿疹のような皮
膚科疾患に用いられ、通常0.1〜0.5%処方され
る。このアラントインは加水分解されやすく、例
えば酸性ではグリオキシル酸と尿素となり、アル
カリ性ではアラントイン酸に分解されることが知
られているが、その正確な定量も行なわれていな
かつたため経時的にかなりの含量減少が起つてい
たと思われる。 そこで本発明者は、アラントインを配合した外
用剤につき、含量減少が許容範囲内であり、長期
間にわたつて異臭や着色変化、粘度変化等を生じ
ず使用感の優れたものを得るため鋭意研究の結果
本発明を完成した。 すなわち本発明は、アラントインを主成分と
し、カルボキシビニルポリマーと水を含みPHを
5.5以下に調整した外用剤である。 カルボキシビニルポリマーは、化粧品原料基準
にも収載されており、アクリル酸を主とし、アリ
ル蔗糖などと共重合させたものであり、中和によ
り優れた増粘効果を奏することが知られていて、
カーボポール、ジユンロン、ハイビスワコー等の
名称で市販されている。 カルボキシビニルポリマーは一般に0.1〜10%
程度処方され、水酸化ナトリウム、水酸化カリウ
ム等の塩基性無機物またはエタノールアミン等の
塩基性有機物で中和し、PH5.5〜11としたときに
最も優れた効果が得られるとされている。しかし
ながら、本発明者の研究によりアラントインを外
用剤に配合するときは、PHが5.5をアルカリ性側
に越える場合は長期間の保存によりアラントイン
の含量が90%を下まわる例も生じることが認めら
れたので、これ以下のPHでの使用可能性を更に検
討したところ、カルボキシビニルポリマーを用い
てPHを5.5以下とした場合でもコロイド化学的に
安定なゲル状外用剤が得られ、PH緩衝作用も発揮
されることが確められた。 本発明の外用剤にはアラントインとカルボキシ
ビニルポリマーおよび水の他にも、一般に外用剤
に配合される成分を加えてもよく、例えば皮膚保
護作用を示す油成分としてワセリン、流動パラフ
イン、スクアラン等の炭化水素類、セチルアルコ
ール、ステアリルアルコール等の高級アルコール
類およびパルミチン酸、ステアリン酸等の高級脂
肪酸類が挙げられる。また保湿剤としてグルセリ
ン、ソルビトール、プロピレングリコール等、防
腐剤としてヒドロキシ安息香酸メチル等のフエノ
ール誘導体、塩化ベンザルコニウム等の逆性セツ
ケン、ソルビン酸、デヒドロ酢酸、ホウ酸等、さ
らに香料、色素等を加えてもよい。さらに、軟
膏、クリーム剤等を調製する際に乳化剤として界
面活性剤、特に合成界面活性剤がよく使用される
がこれらを加えることもできる。例を挙げるとソ
ルビタン脂肪酸エステル(スパン類)、ポリオキ
シエチレンソルビタン脂肪酸エステル(トウイー
ン類)、ポリオキシエチレングリコールアルキル
エーテル、ポリオキシエチレングリコール脂肪酸
エステル等の非イオン性界面活性剤、塩化ベンザ
ルコニウム、塩化ベンゼトニウム等の陽イオン性
活性剤、アルキル硫酸ナトリウム等の陰イオン性
活性剤等である。ただし、界面活性剤を用いると
コロイド化学的には安定なクリームを得ることが
できるが、皮膚刺激が皮膚毒性の点で界面活性剤
の使用は好ましくない。 本発明の外用剤はこれらの界面活性剤の使用が
可能ではあるが必須ではなく、配合しない場合で
も使用感に優れ、経時安定性が良い点に特徴を有
する。 製造方法としては、一般的な外用剤の製法でよ
く、例えばパラフイン、スクアラン等の油層成分
とグリセリン、プロピレングリコール、水等の水
層成分を別々に50〜80℃に加温し、その後両者を
撹拌しながら混合する。次に撹拌を続けながら室
温に到達するまで冷却する。カルボキシビニルポ
リマーは油層成分に添加させても良く、またグリ
セリン、プロピレングリコール等の水層成分に分
散させた上で添加しても均一溶解することが出来
る。 以下に実施例および比較例を示し詳細に説明す
る。 実施例 アラントイン 0.4重量部 カーボポール934 1.0 〃 スクアラン 10.0重量部 1,3―ブチレングリコール 5.0 〃 パラオキシ安息香酸エチル 0.1 〃 水酸化ナトリウム 適量 精製水 全量を100重量部とする。 スクアランにカーボポール934(グツドリツチ社
製カルボキシビニルポリマー)を均一に分散さ
せ、懸濁させた油層成分を調製する。一方精製水
を約50℃に加温し、撹拌しながらパラオキシ安息
香酸エチル、1,3―ブチレングリコールおよび
アラントインを添加し、溶解した後、さきの油層
成分を加え、10分間撹拌する。次に水酸化ナトリ
ウムを加えてPH4±0.2,5±0.2,6±0.2または
7±0.2に調整したのち撹拌しつつ室温になるま
で冷やした。 比較例 1 o/w型 親水軟膏(日本薬局方第十改正) アラントイン 0.4重量部 白色ワセリン 25.0 〃 ステアリルアルコール 22.0 〃 プロピレングリコール 12.0重量部 ラウリル硫酸ナトリウム 1.5 〃 パラオキシ安息香酸エチル 0.025 〃 パラオキシ安息香酸プロピル 0.015 〃 精製水 全量を100重量部とする。 白色ワセリン及びステアリルアルコールを水浴
上で溶かし、かき混ぜて約75℃に保ち、これにあ
らかじめアラントインを精製水に溶かして75℃に
加温した液を加え、固まるまでかき混ぜた。 比較例 2 w/o型 吸水軟膏(日本薬局方第十改正) アラントイン 0.4重量部 白色ワセリン 40 〃 セタノール 18 〃 セスキオレイン酸ソルビタン 5 〃 ラウロマクロゴール 0.5 〃 パラオキシ安息香酸エチル 0.1 〃 パラオキシ安息香酸プロピル 0.1 〃 精製水 全量を100重量部とする。 白色ワセリン、セタノール、パラオキシ安息香
酸プロピル、ラウロマクロゴールおよびセスキオ
レイン酸ソルビタンをとり、水浴上で75℃に加温
して溶解し、油層成分とする。別に精製水にアラ
ントインおよびパラオキシ安息香酸エチルを加え
80℃に加温して溶解した液を徐々に油層成分に加
えてかき混ぜ、加温を止め固まるまでかき混ぜ
た。 比較例1および2は第十改正日本薬局方親水軟
膏および吸水軟膏にアラントインを処方したもの
である。 上記実施例および比較例について5人のパネラ
ーに使用させ、使用時のベトツキ、のび、清涼感
の官能評価をおこなつた。 その結果は表1に示したとおりであり、実施例
の外用剤が使用時のベトツキ、のびおよび清涼感
等の官能面で最も優れている。
The present invention relates to an external preparation containing allantoin as a main ingredient. The term "external preparations" as used herein refers to medical and cosmetic preparations that are used externally to protect the face, limbs, etc., and keep them in a healthy condition. Allantoin is listed in the Standards for Cosmetic Ingredients and is used to treat wounds, ulcers, burns, etc. and for dermatological diseases such as eczema, and is usually prescribed at 0.1 to 0.5%. Allantoin is easily hydrolyzed; for example, it is known to be decomposed into glyoxylic acid and urea in acidic conditions, and to allantoic acid in alkaline conditions, but as accurate quantification has not been carried out, the content decreases considerably over time. seems to have occurred. Therefore, the present inventor conducted extensive research in order to obtain a topical preparation containing allantoin in which the content reduction is within an acceptable range, and which has an excellent feeling of use without causing any off-odor, color change, or viscosity change over a long period of time. As a result, the present invention was completed. In other words, the present invention has allantoin as the main component, contains carboxyvinyl polymer and water, and has a pH control.
This is an external preparation adjusted to 5.5 or less. Carboxyvinyl polymer is also listed in the Cosmetic Raw Materials Standards, and is mainly made of acrylic acid, copolymerized with allyl sucrose, etc., and is known to have an excellent thickening effect when neutralized.
It is commercially available under names such as Carbopol, Jiyunron, and Hibiswako. Carboxyvinyl polymers are generally 0.1-10%
It is said that the best effects are obtained when the pH is adjusted to 5.5-11 by neutralizing with basic inorganic substances such as sodium hydroxide and potassium hydroxide, or basic organic substances such as ethanolamine. However, the inventor's research has shown that when allantoin is added to external preparations, if the pH exceeds 5.5 on the alkaline side, the allantoin content may drop below 90% due to long-term storage. Therefore, we further investigated the possibility of using it at a pH lower than this, and found that even when the pH was lowered to 5.5 or lower using carboxyvinyl polymer, a gel-like external preparation was obtained that was colloidally stable and also exhibited a pH buffering effect. It was confirmed that it would be done. In addition to allantoin, carboxyvinyl polymer, and water, the external preparation of the present invention may contain other ingredients that are generally included in external preparations, such as petrolatum, liquid paraffin, squalane, etc., as an oil component that has a skin protective effect. Examples include hydrocarbons, higher alcohols such as cetyl alcohol and stearyl alcohol, and higher fatty acids such as palmitic acid and stearic acid. In addition, moisturizing agents such as glycerin, sorbitol, and propylene glycol, preservatives such as phenol derivatives such as methyl hydroxybenzoate, antiseptics such as benzalkonium chloride, sorbic acid, dehydroacetic acid, and boric acid, as well as fragrances and pigments, etc. May be added. Furthermore, surfactants, especially synthetic surfactants, are often used as emulsifiers when preparing ointments, creams, etc., and these can also be added. Examples include nonionic surfactants such as sorbitan fatty acid esters (spans), polyoxyethylene sorbitan fatty acid esters (tweens), polyoxyethylene glycol alkyl ethers, polyoxyethylene glycol fatty acid esters, benzalkonium chloride, These include cationic activators such as benzethonium chloride, anionic activators such as sodium alkyl sulfate, and the like. However, although it is possible to obtain a colloidally chemically stable cream by using a surfactant, the use of a surfactant is not preferable because it causes skin irritation and toxicity. Although the use of these surfactants is possible in the external preparation of the present invention, it is not essential, and even when they are not incorporated, the preparation is characterized by excellent feeling on use and good stability over time. The manufacturing method may be a general manufacturing method for external preparations, for example, oil layer components such as paraffin and squalane and water layer components such as glycerin, propylene glycol, and water are heated separately to 50 to 80°C, and then both are heated. Mix while stirring. It is then cooled with continued stirring until it reaches room temperature. The carboxyvinyl polymer may be added to the oil layer component, or it can be uniformly dissolved even if it is added after being dispersed in the water layer component such as glycerin or propylene glycol. Examples and comparative examples will be shown below and explained in detail. Examples Allantoin 0.4 parts by weight Carbopol 934 1.0 Squalane 10.0 parts by weight 1,3-butylene glycol 5.0 Ethyl paraoxybenzoate 0.1 Sodium hydroxide Appropriate amount Purified water The total amount is 100 parts by weight. An oil layer component is prepared by uniformly dispersing and suspending Carbopol 934 (carboxyvinyl polymer manufactured by Gutudoritsu) in squalane. Meanwhile, warm purified water to about 50°C, add ethyl paraoxybenzoate, 1,3-butylene glycol, and allantoin while stirring, and after dissolving, add the oil layer components and stir for 10 minutes. Next, sodium hydroxide was added to adjust the pH to 4±0.2, 5±0.2, 6±0.2 or 7±0.2, and the mixture was cooled to room temperature while stirring. Comparative example 1 O/W type hydrophilic ointment (Japanese Pharmacopoeia 10th revision) Allantoin 0.4 parts by weight White petrolatum 25.0 〃 Stearyl alcohol 22.0 〃 Propylene glycol 12.0 parts by weight Sodium lauryl sulfate 1.5 〃 Ethyl paraoxybenzoate 0.025 〃 Propyl paraoxybenzoate 0.015 〃 Purified water The total amount is 100 parts by weight. White petrolatum and stearyl alcohol were dissolved on a water bath, stirred, and kept at about 75°C. To this was added a solution in which allantoin had been previously dissolved in purified water and heated to 75°C, and stirred until solidified. Comparative example 2 w/o type water-absorbing ointment (Japanese Pharmacopoeia 10th revision) Allantoin 0.4 parts by weight White petrolatum 40 Setanol 18 Sorbitan sesquioleate 5 Lauromacrogol 0.5 Ethyl paraoxybenzoate 0.1 Propyl paraoxybenzoate 0.1 〃 Purified water The total amount is 100 parts by weight. Take white petrolatum, cetanol, propyl paraoxybenzoate, lauromacrogol, and sorbitan sesquioleate, and dissolve by heating to 75°C on a water bath to obtain an oil layer component. Separately, add allantoin and ethyl paraoxybenzoate to purified water.
The solution heated to 80°C and dissolved was gradually added to the oil layer components and stirred, then the heating was stopped and the mixture was stirred until solidified. In Comparative Examples 1 and 2, allantoin was prescribed in a hydrophilic ointment and a water-absorbing ointment according to the 10th edition of the Japanese Pharmacopoeia. The above Examples and Comparative Examples were used by five panelists, and sensory evaluations of stickiness, spreadability, and refreshing sensation upon use were conducted. The results are shown in Table 1, and the external preparations of Examples were the most excellent in terms of sensory aspects such as stickiness, spreadability, and refreshing feeling during use.

【表】【table】

【表】 実施例の外用剤を室温で3ケ月および40℃で3
ケ月間保存し、外観(肉眼判定)、使用感および
アラントイン含量を測定し、表2に示した試験結
果が得られた。
[Table] The external preparation of the example was used for 3 months at room temperature and 3 months at 40℃.
The product was stored for several months, and the appearance (judgment with the naked eye), feeling of use, and allantoin content were measured, and the test results shown in Table 2 were obtained.

【表】 アラントイン含量は高速液体クロマトグラフイ
ー法によつて定量した。 表2からわかるとおり室温3ケ月および40゜3ケ
月の保存をとおし本発明の外用剤は、PH4〜7の
範囲に調製した各試料ともに外観変化および使用
感に変化は全く認められなかつた。しかし、アラ
ントイン含量はPH4およびPH5のものが最も優れ
ており、PH6〜7と高くするとアラントインの含
量低下が認められた。 なお、外用剤のPHを4より小さくすることはヒ
フに対して好ましくないので、PH4〜5.5に調整
するのが適当である。
[Table] Allantoin content was determined by high performance liquid chromatography. As can be seen from Table 2, when the external preparation of the present invention was stored at room temperature for 3 months and at 40°C for 3 months, no change was observed in the appearance or feel of each sample prepared to have a pH in the range of 4 to 7. However, the allantoin content was the best at PH4 and PH5, and when the pH was increased to 6 to 7, a decrease in the allantoin content was observed. In addition, since it is not preferable for Hif to lower the pH of the external preparation to less than 4, it is appropriate to adjust the pH to 4 to 5.5.

Claims (1)

【特許請求の範囲】 1 アラントインを主成分とし、カルボキシビニ
ルポリマーと水を含みPHを5.5以下に調整した外
用剤。 2 界面活性剤を含まない特許請求の範囲第1項
の外用剤。
[Claims] 1. An external preparation containing allantoin as a main component, a carboxyvinyl polymer and water, and having a pH adjusted to 5.5 or less. 2. The external preparation according to claim 1, which does not contain a surfactant.
JP2044982A 1982-02-10 1982-02-10 Preparation for external purpose Granted JPS58140013A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2044982A JPS58140013A (en) 1982-02-10 1982-02-10 Preparation for external purpose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2044982A JPS58140013A (en) 1982-02-10 1982-02-10 Preparation for external purpose

Publications (2)

Publication Number Publication Date
JPS58140013A JPS58140013A (en) 1983-08-19
JPH0158165B2 true JPH0158165B2 (en) 1989-12-11

Family

ID=12027368

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2044982A Granted JPS58140013A (en) 1982-02-10 1982-02-10 Preparation for external purpose

Country Status (1)

Country Link
JP (1) JPS58140013A (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH072618B2 (en) * 1985-12-09 1995-01-18 株式会社小林コ−セ− Makeup remover
WO1994017780A1 (en) * 1993-02-11 1994-08-18 Beiersdorf Ag Waterproof cosmetic or dermatological photoprotective preparations
US6864274B2 (en) * 1999-07-23 2005-03-08 Alwyn Company, Inc. Allantoin-containing skin cream
US6281236B1 (en) * 1999-07-23 2001-08-28 Alwyn Company, Inc. Oil-in-water emulsion with improved stability
US20020055531A1 (en) * 1999-07-23 2002-05-09 Elliott Farber Methods for treatment of inflammatory diseases
US6329413B1 (en) * 1999-07-23 2001-12-11 Alwyn Company, Inc. Allantoin-containing skin cream
US6896897B2 (en) 1999-07-23 2005-05-24 Alwyn Company, Inc. Flexible applicator for applying oil-in-water emulsion with improved stability
US20020054895A1 (en) * 1999-07-23 2002-05-09 Alwyn Company, Inc. Allantoin-containing skin cream
CA2408689A1 (en) * 2000-05-12 2001-11-22 Alwyn Company, Inc. Allantoin-containing skin cream
US20140135372A1 (en) 2010-02-02 2014-05-15 Elliott Farber Compositions and methods of treatment of inflammatory skin conditions using allantoin

Also Published As

Publication number Publication date
JPS58140013A (en) 1983-08-19

Similar Documents

Publication Publication Date Title
JPS60142920A (en) Anti-acne agent
JPH02121915A (en) Waterproofing cream conditioner
JPH08208488A (en) Skin preparation for external use
CA2216574C (en) High electrolyte content oil-in-water emulsion and its use for dermatological/cosmetic purposes, specifically for treating irritated and/or sensitive skin.
KR20100041684A (en) Self tanning compositions containing dihydroxyacetone, a retinoid and ascorbic acid glucoside as a stabilizer
JPH03220129A (en) Sebum suppressant
CA3111314A1 (en) Semi-solid oil-based pharmaceutical compositions containing pirfenidone for application in tissue repair
JPH0158165B2 (en)
JPH03178916A (en) Skin external agent
AU2009256524B2 (en) Compositions for treating rosacea comprising chitosan and a dicarboxylic acid
JPS6360910A (en) Skin drug for external use
KR100638054B1 (en) Cosmetic composition for moisturizing skin containing mixed composition of xylitylpolyglucoside, xylitan and xylitol
JPS6026086B2 (en) cosmetics
JPS60116618A (en) Cosmetic
JPS6256411A (en) Beautifying agent
JP3057207B2 (en) External preparation for skin
JPH01100114A (en) External preparation for skin
JPH0429934A (en) Externally applicable composition containing extracted essence of ginkgo leaf
KR20210050957A (en) Cosmetic composition of sunscreen with titanium dioxide powder dispersed in both of oil phase and water phase
JPH01100113A (en) External preparation for skin
JP2522803B2 (en) Cosmetics
JP3215133B2 (en) Anti-inflammatory analgesic external preparation
JPS60116616A (en) Cosmetic
JPH0692833A (en) Skin external agent
JPH10316523A (en) Oil-in-water type emilsified composition